SG Americas Securities, LLC - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 86 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$25
-7.4%
18,591
+25.0%
0.00%
Q2 2023$27
-80.7%
14,868
-58.5%
0.00%
-100.0%
Q1 2023$140
-99.8%
35,864
+135.7%
0.00%
+100.0%
Q3 2022$83,000
-79.8%
15,214
-83.3%
0.00%
-75.0%
Q2 2022$411,000
+170.4%
91,233
+284.7%
0.00%
+300.0%
Q4 2021$152,000
-38.2%
23,716
-43.8%
0.00%0.0%
Q3 2021$246,000
+43.9%
42,199
+159.4%
0.00%0.0%
Q1 2021$171,000
-81.7%
16,269
-74.5%
0.00%
-83.3%
Q3 2020$932,000
+135.9%
63,865
+206.3%
0.01%
+100.0%
Q2 2020$395,000
+70.3%
20,850
+72.7%
0.00%
+50.0%
Q1 2020$232,000
+38.9%
12,074
+38.5%
0.00%0.0%
Q4 2019$167,000
+72.2%
8,719
-13.6%
0.00%
+100.0%
Q4 2017$97,000
-32.6%
10,094
-23.0%
0.00%0.0%
Q3 2017$144,000
+54.8%
13,116
+28.0%
0.00%0.0%
Q2 2017$93,000
-35.4%
10,249
-33.2%
0.00%0.0%
Q4 2016$144,000
-11.7%
15,343
-0.9%
0.00%0.0%
Q3 2015$163,000
-18.1%
15,482
+190.6%
0.00%0.0%
Q4 2014$199,000
+76.1%
5,327
+64.4%
0.00%0.0%
Q3 2014$113,000
-38.6%
3,241
-18.2%
0.00%0.0%
Q2 2014$184,0003,9610.00%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Consonance Capital Management LP 7,180,700$137,941,00010.27%
Palo Alto Investors LP 4,299,901$82,601,0006.92%
Fairmount Funds Management LLC 562,351$10,803,0006.55%
Avoro Capital Advisors LLC 7,000,000$134,470,0004.54%
Pinz Capital Management, LP 8,820$1,694,0004.44%
Birchview Capital, LP 148,000$2,843,0002.52%
Elk Creek Partners, LLC 699,951$13,446,0002.31%
Parkman Healthcare Partners LLC 215,802$4,146,0001.92%
EAM Global Investors LLC 136,402$2,620,0001.53%
SPHERA FUNDS MANAGEMENT LTD. 550,000$10,566,0001.32%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders